Company Profile

Ravata Solutions Inc
Profile last edited on: 5/22/2023      CAGE: 7V5G4      UEI: HMFQJDGYEKN5

Business Identifier: Tools and equipment required to improve fertility and reproduction outcomes
Year Founded
2017
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2020 5th Street
Davis, CA 95617
   (530) 309-8789
   contact@ravatasolutions.com
   www.ravatasolutions.com
Location: Single
Congr. District: 03
County: Yolo

Public Profile

Ravata Solutions Inc is structured around building sensors to quantify the health of embryos for the IVF industry: build instrumentation that - with minimal operator interventioncan electronically - can assess the health of an embryo of any species. Specializing in hardware and diagnostics to transform the IVF laboratory with automated assisted reproductive technologies (AART), the firm's flagship device improves human disease model development used in pre-clinical studies with implications in improving drug efficacy, medical genetics research, and single zygote CRISPR applications. The firm's product line in development for IVF clinicians and embryo transfer specialists is designed to assist in identifying the healthiest embryo for improved pregnancy rates.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $144,560
Project Title: Same day embryo viability sensor for high throughput embryo transfer selection

Key People / Management

  Yusha Bey -- Head of Engineering: CTO and Co-Founder

  Gurkern S Sufi

Company News

There are no news available.